Jobs
View more job listings or post a job
Cytokinetics Research Associate II - Senior Research Associate, DMPK
Cytokinetics Research Associate III/Senior Research Associate, HTS-Discovery Biology
Cytokinetics Research Associate III/Senior Research Associate, Discovery Biology
PHARMA INVENTOR, INC. – Canadian Chemical Research Company Research Scientist – Synthetic Chemistry
Aimmune Therapeutics Project Coordinator, Analytical Development & Quality Control – (Contractor)
Aimmune Therapeutics Quality Technical Reviewer, Analytical Development & Quality Control – (Contractor)
Gilead Sciences, Inc. Research Scientist II - Drug Metabolism  
Gilead Sciences, Inc. Associate Scientist II - Drug Metabolism
Gilead Sciences, Inc. Research Scientist I - Nonclinical Safety & Pathobiology  
Gilead Sciences, Inc. Senior Research Associate I, Pathobiology
Post a job

Workshop

Understanding and Overcoming High Clearance and Poor Bioavailability: Fundamentals, Investigations and Strategies for Drug Discovery


Speakers: Matthew Wright (Genentech), Vahid Zia (Gilead), Simon Wong (Genentech), Eugene Chen (Genentech), Jaochim Rudolph (Genentech), John Link (Gilead), Fabio Broccatelli (Genentech), Bernard Murray (Gilead)
Organizers: Matthew Wright (Genentech)
Date: 5/22/2018
Time: 8:45-17:00
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For vendor-show rep: $35; For major-sponsor rep (incl lunch): $0;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Catalent Pharma Solutions; Worldwide Clinical Trials
Vendor show vendors registered to date: (18)Absorption Systems; ACROBiosystems; BioDuro; Celerion; ChemPartner; Cyprotex; Cytovier; Foster Delivery Science; Intertek; Pacific BioLabs; Pion Inc.; Q2 Solutions; QPS; Quotient Sciences; Sekisui XenoTech, LLC; Selvita Inc.; Seventh Wave; Simulations Plus, Inc.
Registration: http://www.PBSS.org
Registration deadline:5/21/2018  (it will close sooner if the seating cap is reached)

About the Topic

Poor exposure following oral administration is a common challenge facing discovery programs and consequently a frequent focus for DMPK scientists. Frequently, potent compounds cannot be further developed due to less-than-ideal ADME (absorption, distribution, metabolism, and excretion) properties that prevent the compounds to be available following oral administration. Beyond the discovery phase the importance of understanding and optimizing oral exposure continues in the preclinical and ultimately clinical phases of drug development. Inadequate oral exposure could be due to suboptimal physicochemical properties, or problems in absorption from the gut, or first-pass metabolism in the gut and liver, or high intrinsic clearance of the compounds.

The focus of this workshop/symposium is on: 1) to identify and learn about the issues that contribute to low oral exposure, 2) to discuss approaches that one could use to overcome those challenges, 3) to present additional methodologies that can aid in solving exposure problems and 4) to provide suggestions on how to work with partners in Medicinal Chemistry and Biological Sciences within Project Teams.

This workshop/symposium will cover the following topics:

  • Pharmacokinetic concepts – absorption, bioavailability, and clearance factors contributing to low oral exposure
  • Physiological factors that affect oral exposure
  • Physicochemical factors that influence oral exposure
  • Metabolism-based issues that give rise to poor oral exposure
  • Transporter-based issues that give rise to poor oral exposure
  • How to identify the source of problem in oral exposure – properties of the molecules or conditions of the experiment?
  • Biopharmaceutical Aspects of oral drug exposure
  • Approaches to overcome oral exposure issues, including case studies
  • Enabling Exposure of ADME Challenged compounds
  • What do Medicinal Chemists/Biologists want and how can we work with them

Workshop Agenda:

8:45 - 8:50am  PBSS Welcome M. Wright

8:50 - 9:25am  1. Pharmacokinetic Concepts (Matthew Wright)

9:25 – 10:00 am  2. Absorption of Drugs from the GI Tract (Vahid Zia)

10:00 - 10:20am  Major Sponsor Presentation Worldwide Clinical Trials

10:20 - 10:35am  Break

10:35 - 11:20pm  3. Metabolism-based issues in oral bioavailability (Simon Wong)

11:20 – 12:00 pm  4. Transporter-based issues in oral bioavailability (Eugene Chen)

12:00 - 1:00pm  Lunch

Minisymposium Agenda:

1:00 – 1:45 pm 1. Enabling Technologies to achieve oral exposure (Jaochim Rudolph)

1:45 – 2:30 pm  2. Working in non-Lipinski Space - Discovery of GS-5885 (Ledipasvir) (John Link)

2:30 - 2:45pm  Major Sponsor Presentation Vendor name TBD

2:45 - 3:00pm  Break

3:00 - 3:45pm  3. In silico applications (Fabio Broccatelli)

3:45 – 4:00 pm Break

4:00 - 4:45pm  4. Characterization and differentiation of apparently metabolically stable compounds (Bernard Murray)

4:45 - 5:00pm  Wrap-up (Matthew Wright)


2018-09-12, Antibody Drug Conjugates: Chemistry, Biology, Pharmacokinetics and Toxicology
2018-09-27, Small Molecule Formulation Development: Strategies for challenging APIs (jointly with AAPS-BADG)
2018-10-16, Drug-Drug Interactions: Preclinical Risk Assessment and Review of the new FDA Guidance
2018-11-01, cGMP Compliance for Quality Control and Laboratory Operations
2018-11-16, Protein therapeutics and biomarkers: Recent developments in characterization and quantification by hybrid LC-MS
2018-12-04, Challenges in Peptide Discovery & Drug Development: Biology, Chemistry, PK, Delivery, Regulatory and Beyond
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
©Pharmaceutical & BioScience Society, International; Last Modified: 8/20/2018; Visited: 1478; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
Simulations Plus GastroPlus™ developers launch PKPlus™. Generate validated PK reports for regulatory submissions. Value pricing/licensing. Request an evaluation today.
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Simulations Plus Are you ready to integrate in silico modeling & simulation to augment your research activities, but don’t have the time or resources? We can help!
Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Hypha Discovery Specialists in provision of drug metabolites at mg-g scale, including CYP/Non-CYP metabolites and conjugates such as glucuronides/sulfates.
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
Origin Bioanalytical Laboratory A contract research organization for bioanalytical LC-MS/MS analysis specializing in ocular tissues/fluids located Rancho Cordova, CA
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Simulations Plus The new ADMET Predictor™ 8.5 - Powerful ADMET Property Estimation, at your fingertips! Request an evaluation today.
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
BIOTECH WEEK BOSTON - Sept. 4-7 Join us at Biotech Week Boston - Where Big Science and Bright Minds Meet. Sept. 4-7, 2018 at Hynes Convention Center.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
UC Davis UC Davis Liquid Chromatography/Mass Spectrometry and Confirmation Supervisor Apply Online: http://50.73.55.13/counter.php?id=139228 UC Davis i
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact: kelvin.lam@reactionbiology.com
Submit a Text Ad